BioSpace News Archive

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results of operations for the second quarter of 2019, achieving the outlook set for net sales growth and adjusted earnings per share at constant exchange rates (CER).

Innoviva, Inc. (NASDAQ:INVA) (the Company) today reported financial results for the second quarter ended June 30, 2019.

Stratify Genomics, a pioneer in genetic testing for cancer risk, is pleased to announce it has successfully raised a third Seed Series investment of $2.2 million from angel investors.

Acerus Pharmaceuticals Corporation announced that NATESTO® is now on formulary and covered nationwide by a leading national pharmacy benefit manager in the United States.

Drawbridge Health, a healthcare technology company streamlining the blood draw process for both patients and healthcare providers, announced it has completed a strategic international financing.

Ikonopedia showcases its recently released Automated Combined Reporting package and its entire suite of structured breast reporting and MQSA management tools designed to improve reporting efficiency, and optimize facility operations, here, at AHRA 2019, July 21-24, 2019, (Booth #1318).

Real Time Medical Systems (Real Time), the leading healthcare interventional analytics company connecting long-term care facilities, hospitals, ACOs, payers, and affiliated providers, expands their coordinated care efforts within the south-west through their recent partnership with Creative Solutions in Healthcare (Creative Solutions).

“Accessibility: Transforming Users’ Experience” was the key theme of the 8th annual M-Enabling Summit held in Washington, DC June 17-19, 2019.

CureMatch is pleased to announce the hire of Yekaterina Khotskaya as vice president of clinical operations.

A newly passed law in Washington state represents a significant increase in health care autonomy for its patients.